Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A2

被引:26
|
作者
Nagano, Joseph M. G. [1 ,2 ]
Hsu, Ku-Lung [1 ,2 ]
Whitby, Landon R. [1 ,2 ]
Niphakis, Micah J. [1 ,2 ]
Speers, Anna E. [1 ,2 ]
Brown, Steven J. [1 ,3 ]
Spicer, Timothy [4 ]
Fernandez-Vega, Virneliz [4 ]
Ferguson, Jill [1 ,3 ]
Hodder, Peter [4 ,5 ]
Srinivasan, Prabhavathi [6 ]
Gonzalez, Tara D. [6 ]
Rosen, Hugh [1 ,3 ]
Bahnson, Brian J. [6 ]
Cravatt, Benjamin F. [1 ,2 ]
机构
[1] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Mol Screening Ctr, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Mol Screening Ctr, Lead Identificat Div, Jupiter, FL 33458 USA
[5] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA
[6] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA
基金
美国国家卫生研究院;
关键词
Phospholipase; Inhibitor; Screening; Proteomics; ACTIVATING-FACTOR ACETYLHYDROLASE; CORONARY-ARTERY-DISEASE; PROSTATE-CANCER; HEART-DISEASE; IDENTIFICATION; METABOLISM; DARAPLADIB; MECHANISM; ENZYMES; PLA2G7;
D O I
10.1016/j.bmcl.2012.11.061
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2) or PLA(2)G7) binds to low-density lipoprotein (LDL) particles, where it is thought to hydrolyze oxidatively truncated phospholipids. Lp-PLA(2) has also been implicated as a pro-tumorigenic enzyme in human prostate cancer. Several inhibitors of Lp-PLA(2) have been described, including darapladib, which is currently in phase 3 clinical development for the treatment of atherosclerosis. The selectivity that darapladib and other Lp-PLA(2) inhibitors display across the larger serine hydrolase family has not, however, been reported. Here, we describe the use of both general and tailored activity-based probes for profiling Lp-PLA(2) and inhibitors of this enzyme in native biological systems. We show that both darapladib and a novel class of structurally distinct carbamate inhibitors inactivate Lp-PLA(2) in mouse tissues and human cell lines with high selectivity. Our findings thus identify both inhibitors and chemoproteomic probes that are suitable for investigating Lp-PLA(2) function in biological systems. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:839 / 843
页数:5
相关论文
共 50 条
  • [1] Lipoprotein-associated phospholipase A2 inhibitors
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (07) : 301 - 301
  • [2] Inhibitors of lipoprotein-associated phospholipase A2
    Barrett, D
    Barlocco, D
    DRUG DISCOVERY TODAY, 2001, 6 (05) : 269 - 270
  • [3] Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors
    Ryan J. Chauffe
    Robert L. Wilensky
    Emile R. Mohler
    Current Atherosclerosis Reports, 2010, 12 : 43 - 47
  • [4] Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors
    Chauffe, Ryan J.
    Wilensky, Robert L.
    Mohler, Emile R., III
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (01) : 43 - 47
  • [5] Lipoprotein-associated phospholipase A2
    McConnell, Joseph P.
    Hoefner, Daniel M.
    CLINICS IN LABORATORY MEDICINE, 2006, 26 (03) : 679 - +
  • [6] Advantages of the lipoprotein-associated phospholipase A2 activity assay
    Donato, Leslie J.
    Meeusen, Jeffrey W.
    Callanan, Heidi
    Saenger, Amy K.
    Jaffe, Allan S.
    CLINICAL BIOCHEMISTRY, 2016, 49 (1-2) : 172 - 175
  • [7] Lipoprotein-associated phospholipase A2 and atherosclerosis
    Wilensky, Robert L.
    Macphee, Colin H.
    CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (05) : 415 - 420
  • [8] LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 AND STROKE
    Alvarez-Perez, F. J.
    Verde, I.
    REVISTA DE NEUROLOGIA, 2009, 49 (02) : 88 - 94
  • [9] Lipoprotein-Associated Phospholipase A2 Activity and Risk of Recurrent Stroke
    Elkind, Mitchell S. V.
    Tai, Wanling
    Coates, Kristen
    Paik, Myunghee C.
    Sacco, Ralph L.
    CEREBROVASCULAR DISEASES, 2009, 27 (01) : 42 - 50
  • [10] Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke
    Elkind, Mitchell S.
    Tai, Wanling
    Coates, Kristen
    Paik, Myunghee
    Sacco, Ralph L.
    STROKE, 2007, 38 (02) : 528 - 528